Comparative Pharmacology
Head-to-head clinical analysis: INFUVITE PEDIATRIC versus MVC PLUS.
Peer-Reviewed Evidence
Head-to-head clinical analysis: INFUVITE PEDIATRIC versus MVC PLUS.
INFUVITE PEDIATRIC vs MVC PLUS
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
INFUVITE PEDIATRIC is a multivitamin preparation that provides essential vitamins (A, B complex, C, D, E, K, and folic acid) that act as cofactors and coenzymes in various metabolic pathways, including energy production, protein and nucleic acid synthesis, and antioxidant defense.
MVC PLUS is a fixed-dose combination of maraviroc, a CCR5 co-receptor antagonist, and lamivudine, a nucleoside reverse transcriptase inhibitor. Maraviroc binds to CCR5 on CD4+ T cells blocking HIV-1 entry; lamivudine inhibits HIV reverse transcriptase via competitive inhibition and chain termination.
INFUVITE PEDIATRIC is not indicated for adult use; adult multivitamin formulations are recommended.
10 mg orally once daily.
None Documented
None Documented
Terminal half-life varies by vitamin: thiamine ~20-30 min; riboflavin ~1.3 h; pyridoxine ~2-3 h; ascorbic acid ~16 d; retinol (vitamin A) ~6-18 h; ergocalciferol (D2) ~2-3 d; alpha-tocopherol (E) ~12 h; phytonadione (K1) ~6-8 h. Clinical context: rapid clearance of water-soluble vitamins necessitates daily dosing; fat-soluble vitamins accumulate with repeated dosing.
Terminal elimination half-life: 12-18 hours (mean 14 hours). Clinically, this supports twice-daily dosing with steady-state achieved in ~3 days.
Excretion of vitamins in Infuvite Pediatric is primarily renal for water-soluble vitamins (B-complex and C), with negligible biliary/fecal elimination. Fat-soluble vitamins (A, D, E, K) are not readily excreted; small amounts may appear in bile/faeces. Specific %: not available due to extensive metabolism and tissue storage.
Renal: ~70% unchanged; Fecal: ~25%; Biliary: <5%
Category C
Category C
Multivitamin
Multivitamin/Mineral Supplement